Defining A Business Model For A Non-Profit Research Core Facility For Nano Delivery Systems Of Nucleic Acid Therapies
Nucleic acid therapies represent a groundbreaking approach in modern medicine, capable of potentially curing previously untreatable diseases by modifying gene expression at the DNA or RNA level. Despite their promise, effective delivery of these therapies remains a significant hurdle. Addressing this challenge is the central mission of the soon-to-be-established Chalmers Precision HealthTech Hub.